Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMC 1023160)

Published in J Clin Pathol on January 01, 1996

Authors

L Halme1, H Rautelin, M Leidenius, T U Kosunen

Author Affiliations

1: Fourth Department of Surgery, Helsinki University Central Hospital, Finland.

Articles cited by this

Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet (1992) 6.28

Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54

The cohort effect and Helicobacter pylori. J Infect Dis (1993) 4.28

Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut (1992) 3.22

Inflammatory bowel disease and domestic hygiene in infancy. Lancet (1994) 3.08

Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis (1992) 2.60

Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol (1989) 2.15

Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11

Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis (1993) 1.59

Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut (1992) 1.30

Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut (1994) 1.28

Life prospects and quality of life in patients with Crohn's disease. Gut (1987) 1.22

Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol (1992) 1.16

Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease. Clin Exp Immunol (1992) 1.16

Articles by these authors

Stability of related human and chicken Campylobacter jejuni genotypes after passage through chick intestine studied by pulsed-field gel electrophoresis. Appl Environ Microbiol (1999) 2.38

Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol (1992) 1.98

Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92

A three-year study of Campylobacter jejuni genotypes in humans with domestically acquired infections and in chicken samples from the Helsinki area. J Clin Microbiol (2000) 1.81

Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol (1992) 1.76

Detection and typing of Campylobacter jejuni and Campylobacter coli and analysis of indicator organisms in three waterborne outbreaks in Finland. Appl Environ Microbiol (2003) 1.75

Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother (1991) 1.72

Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun (1992) 1.71

An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. J Clin Microbiol (1983) 1.65

Serology of Campylobacter fetus ss. jejuni )"related" campylobacters). Demonstration of strain-specific and interstrain-related antigens by immunoelectrophoresis and co-agglutination. Acta Pathol Microbiol Scand B (1980) 1.64

Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol (1990) 1.62

Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol (1998) 1.59

Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect (1997) 1.49

Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol (1991) 1.46

Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis (2006) 1.44

Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43

Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia. Acta Med Scand (1983) 1.41

Campylobacter enteritis in 188 hospitalized patients. Arch Intern Med (1983) 1.41

Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38

Serology of Campylobacter fetus ss. jejuni. 2 Serotyping of live bacteria by slide, latex and co-agglutination tests. Acta Pathol Microbiol Immunol Scand B (1982) 1.30

Reactive arthritis after campylobacter jejuni enteritis in patients with HLA-B27. Lancet (1980) 1.29

Arthritis associated with Campylobacter jejuni enteritis. Scand J Rheumatol (1981) 1.27

Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther (2005) 1.25

Decreasing trend of overlapping multilocus sequence types between human and chicken Campylobacter jejuni isolates over a decade in Finland. Appl Environ Microbiol (2010) 1.21

Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21

Genomic relatedness within five common Finnish Campylobacter jejuni pulsed-field gel electrophoresis genotypes studied by amplified fragment length polymorphism analysis, ribotyping, and serotyping. Appl Environ Microbiol (2001) 1.20

Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol (1996) 1.18

Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen. J Clin Microbiol (1987) 1.16

Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis (1982) 1.16

Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol (1992) 1.16

Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect (2001) 1.16

Temporal and geographical distribution and overlap of Penner heat-stable serotypes and pulsed-field gel electrophoresis genotypes of Campylobacter jejuni isolates collected from humans and chickens in Finland during a seasonal peak. J Clin Microbiol (2003) 1.14

Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol (1998) 1.14

Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol (2000) 1.13

One-year morbidity after sentinel node biopsy and breast surgery. Breast (2005) 1.12

Waterborne outbreak of Campylobacter enteritis after outdoors infantry drill in Utti, Finland. Epidemiol Infect (1989) 1.08

Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis (1996) 1.07

Depression of human neutrophil motility by influenza virus in vitro. Scand J Immunol (1977) 1.06

Heterogeneity of Campylobacter pylori as demonstrated by co-agglutination testing with rabbit antibodies. Scand J Gastroenterol Suppl (1988) 1.05

Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun (1993) 1.05

Effect of ABO blood group and secretor status on the frequency of Helicobacter pylori antibodies. Scand J Gastroenterol (1990) 1.03

High frequency of helicobacter negative gastritis in patients with Crohn's disease. Gut (1996) 1.03

Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS Immunol Med Microbiol (2001) 1.03

Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut (2000) 1.02

Biochemical characterization of Campylobacter fetus lipopolysaccharides. Infect Immun (1994) 1.02

Clinical and serological studies in patients with Campylobacter fetus ssp. jejuni infection: II. Serological findings. Infection (1981) 1.02

Antibodies against an acid extract from a single campylobacter strain in hospitalized campylobacter patients. Infection (1983) 1.01

Carditis and arthritis associated with Campylobacter jejuni infection. Acta Med Scand (1980) 1.01

The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther (2002) 1.01

An outbreak of gastroenteritis from a non-chlorinated community water supply. J Epidemiol Community Health (2004) 1.00

Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol (1994) 0.99

Defective chemotaxis in monosomy-7. Nature (1977) 0.99

Allergy gap between Finnish and Russian Karelia on increase. Allergy (2011) 0.99

Infection with Campylobacter fetus. Scand J Infect Dis (1984) 0.96

Detection of an organ specific protein in the rat thymus. Ann Med Exp Biol Fenn (1966) 0.96

Use of leucocyte migration under agarose to study spontaneous and directed locomotion of leucocytes. Immunology (1978) 0.96

Helicobacter pylori and associated gastroduodenal diseases. Review article. APMIS (1991) 0.96

Function of neutrophils in preleukaemia. Scand J Haematol (1977) 0.95

Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol (1993) 0.95

Analysis of Campylobacter jejuni antigens with monoclonal antibodies. J Clin Microbiol (1984) 0.95

The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer. Eur J Surg Oncol (2002) 0.93

Strain and host characteristics of Campylobacter jejuni infections in Finland. Clin Microbiol Infect (2006) 0.92

Serological analysis of the heat-stable antigens involved in serotyping Campylobacter jejuni and Campylobacter coli. APMIS (1989) 0.92

Three cases of cardiac complications associated with Campylobacter jejuni infection and review of the literature. Eur J Clin Microbiol Infect Dis (2005) 0.92

Genetic and environmental factors in the immunopathogenesis of atopy: interaction of Helicobacter pylori infection and IL4 genetics. Int Arch Allergy Immunol (2005) 0.91

Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J Appl Bacteriol (1995) 0.90

Infection due to Campylobacter jejuni: a report of 524 outpatients. Infection (1984) 0.90

Waterborne Campylobacter jejuni epidemic in a Finnish hospital for rheumatic diseases. Scand J Infect Dis (1990) 0.90

Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains. J Clin Microbiol (2001) 0.90

Phagocytic activity of neutrophilic leukocytes of A2 influenza patients. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 0.89

Patient-reported complications associated with Campylobacter jejuni infection. Epidemiol Infect (2009) 0.88

Evaluation of blood tests to predict normal gastric mucosa. Scand J Gastroenterol (2000) 0.88

Flavodoxin-dependent pyruvate oxidation, acetate production and metronidazole reduction by Helicobacter pylori. J Antimicrob Chemother (1998) 0.88

The impact of sentinel node biopsy and axillary staging strategy on hospital costs. Ann Oncol (2004) 0.88

Survival of Helicobacter pylori From complement lysis by binding of GPI-anchored protectin (CD59). Gastroenterology (2001) 0.88

Gastric inflammation is enhanced in children with CagA-positive Helicobacter pylori infection. Pediatr Infect Dis J (1999) 0.88

Hunt for the origin of allergy - comparing the Finnish and Russian Karelia. Clin Exp Allergy (2015) 0.88

Factors related to frequency, type, and outcome of anal fistulas in Crohn's disease. Dis Colon Rectum (1995) 0.87

In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli. Infect Immun (1999) 0.87

In vitro effect of anti-inflammatory agents on phagocytosis and bacterial killing by human neutrophilic leukocytes. Acta Pharmacol Toxicol (Copenh) (1972) 0.87

Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection. Gut (2003) 0.87

In vitro activity of antifungal azoles against Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1992) 0.86

Change in the pattern of IgE reactivity to timothy grass and birch pollen allergens over a 20-year period. J Investig Allergol Clin Immunol (2006) 0.86

Leukocyte migration agarose test for the assessment of human neutrophil chemotaxis. II. Variables in the attraction assay. Scand J Immunol (1977) 0.86

Breast cancer in very young women. Eur J Surg Oncol (2011) 0.86

Should Helicobacter pylori infection be treated before kidney transplantation? Nephrol Dial Transplant (2001) 0.85

Rate of Helicobacter pylori acquisition among Finnish adults: a fifteen year follow-up. Scand J Gastroenterol (1996) 0.85

Pancreas affection in association with enteritis due to Campylobacter fetus ssp. jejuni. Acta Med Scand (1981) 0.85

Experimental allergic thyroiditis in the guinea pig. IV. Autoradiographic studies of the evolution of the cellular infiltrate. Lab Invest (1966) 0.85